BR112017022941A2 - dispositivo de neuromodulação - Google Patents

dispositivo de neuromodulação

Info

Publication number
BR112017022941A2
BR112017022941A2 BR112017022941-2A BR112017022941A BR112017022941A2 BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2 BR 112017022941 A BR112017022941 A BR 112017022941A BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2
Authority
BR
Brazil
Prior art keywords
methods
treating
signal
neuromodulation device
provides
Prior art date
Application number
BR112017022941-2A
Other languages
English (en)
Portuguese (pt)
Inventor
John Chew Daniel
Jacob De Jonge Wouter
Jakob Kristoffer Famm Hans
Patel Sonal
Welting Olaf
Original Assignee
Galvani Bioelectronics Limited
Academisch Medisch Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvani Bioelectronics Limited, Academisch Medisch Centrum filed Critical Galvani Bioelectronics Limited
Publication of BR112017022941A2 publication Critical patent/BR112017022941A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A61N1/0556—Cuff electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
BR112017022941-2A 2015-04-24 2016-04-22 dispositivo de neuromodulação BR112017022941A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152119P 2015-04-24 2015-04-24
US62/152,119 2015-04-24
PCT/IB2016/052307 WO2016170510A1 (en) 2015-04-24 2016-04-22 Neuromodulation device

Publications (1)

Publication Number Publication Date
BR112017022941A2 true BR112017022941A2 (pt) 2018-07-17

Family

ID=55963419

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017022941-2A BR112017022941A2 (pt) 2015-04-24 2016-04-22 dispositivo de neuromodulação

Country Status (11)

Country Link
US (2) US10974041B2 (enExample)
EP (2) EP3950049A1 (enExample)
JP (1) JP2018514354A (enExample)
KR (1) KR20180040516A (enExample)
CN (1) CN108290041A (enExample)
AU (1) AU2016252497A1 (enExample)
BR (1) BR112017022941A2 (enExample)
CA (1) CA2983652A1 (enExample)
MA (1) MA41950A (enExample)
RU (1) RU2017140776A (enExample)
WO (1) WO2016170510A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013134543A1 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Immune system neuromodulation and associated systems and methods
JP2017536187A (ja) 2014-12-03 2017-12-07 メタベンション インコーポレイテッド 神経または他の組織を調節するためのシステムおよび方法
WO2016197039A1 (en) * 2015-06-05 2016-12-08 The Johns Hopkins University Method and device for sacral nerve stimulation
CN109982629B (zh) 2016-07-07 2023-07-14 加州大学评议会 使用超声波刺激组织的植入物
JP2021507759A (ja) * 2017-12-20 2021-02-25 ガルバニ バイオエレクトロニクス リミテッド 炎症に関連する疾患の治療
US11633601B2 (en) 2017-12-20 2023-04-25 Galvani Bioelectronics Limited Treatment of inflammatory disorders
ES2988485T3 (es) 2017-12-20 2024-11-20 Galvani Bioelectronics Ltd Tratamiento de afecciones médicas agudas
EP4556060A3 (en) 2017-12-20 2025-08-06 Galvani Bioelectronics Limited Treatment of acute medical conditions
EP3727566B1 (en) * 2017-12-20 2024-08-28 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
CN112272575B (zh) 2018-04-19 2024-05-17 艾奧塔生物科技公司 使用用于神经感测和刺激的超声通信的植入物
IL278031B2 (en) * 2018-04-19 2024-10-01 Iota Biosciences Inc Implants using ultrasonic communication for modulating splenic nerve activity
US10974079B2 (en) * 2018-08-29 2021-04-13 General Electric Company Neuromodulation techniques
ES2985924T3 (es) 2018-08-29 2024-11-07 Iota Biosciences Inc Dispositivo implantable de neuromodulación de bucle cerrado
EP3897820A1 (en) * 2018-12-20 2021-10-27 Galvani Bioelectronics Limited Neurostimulation device for blocking blood flow between electrodes
US20220249840A1 (en) * 2019-06-19 2022-08-11 Galvani Bioelectronics Limited Treatment of Acute Medical Conditions
EP3986532A1 (en) * 2019-06-19 2022-04-27 Galvani Bioelectronics Limited System for the treatment of disorders associated with inflammation
WO2020254798A1 (en) * 2019-06-19 2020-12-24 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
KR20220082063A (ko) 2019-10-17 2022-06-16 아이오타 바이오사이언시즈 인코퍼레이티드 암 환자에서 면역 시스템 활동을 조정하고 암을 치료하기 위한 장치 및 방법
JP2023521674A (ja) * 2020-04-09 2023-05-25 ゼネラル・エレクトリック・カンパニイ 生理学的状態を治療するための非侵襲的な集束させた超音波の神経調節
WO2022122833A1 (en) * 2020-12-09 2022-06-16 Galvani Bioelectronics Limited Physiological effects of activation of the alox15 pathway
CN113197587A (zh) * 2021-04-26 2021-08-03 中国科学院深圳先进技术研究院 一种用于迷走神经刺激和电生理检测的装置及植入方法
US20250128063A1 (en) * 2021-08-10 2025-04-24 Galvani Bioelectronics Limited Neuromodulation Device
KR20230078121A (ko) * 2021-11-26 2023-06-02 주식회사 뉴라이브 동물용 미주신경 자극장치
CN114177472A (zh) * 2021-11-30 2022-03-15 中国人民解放军总医院第四医学中心 一种应用于下肢假肢的植入式电刺激感知反馈系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2438541A1 (en) 2001-02-20 2002-08-29 Case Western Reserve University Systems and methods for reversibly blocking nerve activity
US20060116736A1 (en) * 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US20050075702A1 (en) * 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US7418292B2 (en) * 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US8214047B2 (en) * 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
ATE489132T1 (de) 2004-12-27 2010-12-15 The Feinstein Inst Medical Res Behandlung von entzündlichen erkrankungen durch elektrische stimulation des vagus-nervs
US7747324B2 (en) * 2005-11-10 2010-06-29 Electrocore Llc Electrical stimulation treatment of bronchial constriction
JP2009525805A (ja) * 2006-02-10 2009-07-16 エレクトロコア、インコーポレイテッド 電気的変調を用いたアナフィラキシーの治療方法および治療装置
US9539425B2 (en) * 2006-10-13 2017-01-10 Intelect Medical, Inc. Systems and methods for treating medical conditions by stimulation of medial thalamic region
JPWO2008096730A1 (ja) * 2007-02-09 2010-05-20 国立大学法人名古屋大学 抗炎症剤及びその用途
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
US8788034B2 (en) * 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2658605B1 (en) * 2010-12-28 2016-07-27 Cibiem, Inc. Endovascular carotid body ablation catheter for sympathetic rebalancing of patient
CA2834180C (en) 2011-05-19 2019-04-30 Neuros Medical, Inc. High-frequency electrical nerve block
SG11201402610QA (en) * 2011-12-09 2014-10-30 Metavention Inc Therapeutic neuromodulation of the hepatic system
CN104145466A (zh) * 2012-02-24 2014-11-12 诺基亚公司 用于动态服务器/客户端控制的连通性逻辑的方法和装置
WO2013134541A2 (en) * 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Gastrointestinal neuromodulation and associated systems and methods
WO2014153223A1 (en) * 2013-03-14 2014-09-25 Perryman Laura Tyler Treating inflammation, chronic pain and other disorders with neuromodulation

Also Published As

Publication number Publication date
AU2016252497A1 (en) 2017-11-09
WO2016170510A1 (en) 2016-10-27
US20180117319A1 (en) 2018-05-03
MA41950A (fr) 2018-02-28
US20210393949A1 (en) 2021-12-23
CN108290041A (zh) 2018-07-17
CA2983652A1 (en) 2016-10-27
KR20180040516A (ko) 2018-04-20
RU2017140776A (ru) 2019-05-24
JP2018514354A (ja) 2018-06-07
US10974041B2 (en) 2021-04-13
EP3950049A1 (en) 2022-02-09
EP3285856A1 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
BR112017022941A2 (pt) dispositivo de neuromodulação
DK4218640T3 (en) Systems for the treatment of disease states and disorders
EP3758771A4 (en) LIQUID PREPARATION AND TREATMENT DEVICES, METHODS AND SYSTEMS
EP3740274A4 (en) SYSTEMS AND METHODS FOR TREATING INFLAMMATORY INTESTINAL DISEASE USING PERIPHERAL NERVE STIMULATION
EP3405404A4 (en) INTERNAL PROTECTION SYSTEM FOR FLUID AND SOLID TREATMENT DEVICES, USES OF THE SYSTEM
MX383587B (es) Sistemas y métodos para el enlace neuronal del sistema nervioso.
EP3347085A4 (en) DEVICE FOR PERIPHERAL OR SPINAL STIMULATION
EP3271776A4 (en) Methods and systems for diagnosing and treating health ailments
PL3865102T3 (pl) Urządzenie i sposób leczenia zaburzeń neurologicznych układu słuchowego
EP3500267A4 (en) NICOTINAMIDRIBOSIDE AND PTEROSTILLE COMPOSITIONS AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES
BR112017003163A2 (pt) dispositivo de infraestrutura modular, sistema de infraestrutura e processo para operação de um dispositivo de infraestrutura
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
EP3307754A4 (en) NICOTINAMIDRIBOSIDE AND PTEROSTODY COMPOSITIONS AND METHOD FOR TREATING SKIN DISEASES
BR112018000707A2 (pt) ?composições terapêuticas e produto de combinação?
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
TN2017000074A1 (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
PL3157531T3 (pl) Sposoby i kompozycje do stymulacji jelitowego układu enteroendokrynnego w leczeniu chorób lub stanów związanych z tym układem
GB2561300B (en) Method and system for diagnosing disease and generating treatment recommendations
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2024003906A (es) Vedolizumab para el tratamiento de pacientes pediatricos.
EP3365081A4 (en) DEVICE AND SYSTEM FOR BILATERAL HAND REHABILITATION
BR112017026803A2 (pt) adaptador ou sistema adaptador para tornar dispositivos médicos funcionalmente estéreis
EP3357494A4 (en) THERAPEUTIC AGENT AND / OR PROPHYLACTIC AGENT FOR PERIPHERAL NERVOUS DISORDER OR SPINE INJURY
EP3951326C0 (en) METHOD AND SYSTEM ASSOCIATED WITH OPERATING STATES OF A NUMBER OF DEVICES
MX2017004723A (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]